ACTA NEUROPHARMACOLOGICA ›› 2023, Vol. 13 ›› Issue (1): 43-.DOI: 10.3969/j.issn.2095-1396.2023.01.008

Previous Articles     Next Articles

Study on the Mechanism of Platelet-Rich Plasma in the Treatment of Pathological Neuralgia of Lumbar Disc Herniation

YAO Peng-cheng, MA Bin-xiang, CHEN Guo-dong, YAN Wei-ping, GONG Yu-suo, ZHENG Jian-peng, LIU Shuai   

  1. 1. Gansu University of Traditional Chinese Medicine, Lanzhou, 730000, China  2. Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou, 730050, China
  • Online:2023-02-26 Published:2023-11-29

Abstract:

Neuropathic pain (NP) is mostly caused by trauma or disease directly caused by pain or the pain sensation caused by the destruction of the nervous system. It is one of many chronic pains and seriously affects the quality of life of patients. At present, there are many opioids, anticonvulsants, antiepileptic drugs, etc. for the clinical treatment of NP, but the clinical efficacy is not good and adverse reactions will occur. Platelet-rich plasma (PRP) can effectively relieve pathological nerve pain by releasing a variety of bioactive factors, and also has the effect of nerve repair. However, its mechanism of action in the treatment of pathological neuralgia has not been fully clarified. In this paper, the mechanism of action of platelet-rich plasma in the treatment of pathological neuralgia of lumbar disc herniation was studied in order to provide new ideas and methods for clinical diagnosis and treatment.

Key words: platelet-rich plasma, lumbar disc herniation, pathological neuralgia, mechanism of action